Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomer Meirson

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Immunology Research|June 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma CellsNaama Margolis, Hanna Moalem, Tomer Meirson, et al.
Nucleic Acids Research|January 31, 2019
Dysregulation of the cohesin subunit RAD21 by Hepatitis C virus mediates host-virus interactionsShira Perez, Michael Gevor, Ateret Davidovich, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2025
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysisAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
FAK family proteins regulate <i>in vivo</i> breast cancer metastasis <i>via</i> distinct mechanismsAlessandro Genna, Joel Alter, Martina Poletti, et al.
British Journal of Cancer|August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trialsAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Bayesian Interim Analysis and Efficiency of Phase III Randomized TrialsAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Neurology|February 12, 2017
Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndromeAdi Aran, Reeval Segel, Kota Kaneshige, et al.
Neuro-Oncology|January 31, 2025
IRS2 as a driver of brain metastasis in colorectal cancer: a potential target for novel therapeutic strategiesInbal Greenberg, Fayhaa Khair, Keren Merenbakh-Lamin, et al.
Plos Genetics|June 20, 2019
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antiviralsShira Perez, Antony Kaspi, Tom Domovitz, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology TrialsAlexander D Sherry, Yufei Liu, Pavlos Msaouel, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|June 22, 2022
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma CellsNaama Margolis, Hanna Moalem, Tomer Meirson, et al.
Nucleic Acids Research|January 31, 2019
Dysregulation of the cohesin subunit RAD21 by Hepatitis C virus mediates host-virus interactionsShira Perez, Michael Gevor, Ateret Davidovich, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2025
Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysisAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
FAK family proteins regulate <i>in vivo</i> breast cancer metastasis <i>via</i> distinct mechanismsAlessandro Genna, Joel Alter, Martina Poletti, et al.
British Journal of Cancer|August 11, 2025
Bayesian interim analysis and efficiency of phase III randomized trialsAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Bayesian Interim Analysis and Efficiency of Phase III Randomized TrialsAlexander D Sherry, Pavlos Msaouel, Avital M Miller, et al.
Neurology|February 12, 2017
Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndromeAdi Aran, Reeval Segel, Kota Kaneshige, et al.
Neuro-Oncology|January 31, 2025
IRS2 as a driver of brain metastasis in colorectal cancer: a potential target for novel therapeutic strategiesInbal Greenberg, Fayhaa Khair, Keren Merenbakh-Lamin, et al.
Plos Genetics|June 20, 2019
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antiviralsShira Perez, Antony Kaspi, Tom Domovitz, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology TrialsAlexander D Sherry, Yufei Liu, Pavlos Msaouel, et al.
Pageof 6